Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Gudrun Vogtentanz is active.

Publication


Featured researches published by Gudrun Vogtentanz.


Protein Expression and Purification | 2009

Generation and identification of variants with improved purification yield of Bowman-Birk protease inhibitors carrying protein binding loops.

Katherine D. Collier; Gudrun Vogtentanz; Neelam S. Amin; Melodie Estabrook; David A. Estell; Bryan P. Fox; Scott D. Power; Roopali Rao; Brian Schmidt

Replacing the chymotrypsin inhibitory loop of soybean Bowman-Birk inhibitor (sBBI) with a VEGF binding peptide (BBI-AV) significantly reduces the overall purification yield when BBI-AV is produced as a fusion protein in a Bacillussubtilis expression system. The low purification yield is primarily due to a higher fraction of molecules with incorrect disulfide bond configurations after production and also after disulfide bond shuffling induced by 2-mercaptoethanol. To improve production yields, site-saturation libraries were generated at 39 out of the 66 amino acid residues of BBI-AV. Initial screens were designed to select for variants with higher trypsin inhibitory activities than the parent after treatment with a reducing agent. Secondary screens were developed to select for variants with the highest purification yields, and to also eliminate any false positives. From the screens, it was found that positively charged substitutions in the exposed hydrophobic patch region (sites 27, 29, 40, 50 & 52) are especially productive. In fact, one substitution, F50R, improves the purification yield to nearly the same level as wild-type sBBI. Productive amino acid substitutions were combined to select for the variant with the best overall yield after purification. Several variants were obtained with higher purification yields than even sBBI. The octuple variants, A13I-S25R-M27A-L29P-S31A-A40H-F50K-V52T and A13I-S25K-M27A-L29R-S31E-A40K-F50Q-V52Q, are particularly productive having greater than a five fold increase in final purification yield over the parent.


Archive | 2006

Personal care compositions and methods for their use

Katherine D. Collier; Anthony G. Day; Nobel Hans De; David A. Estell; Grant Ganshaw; Marc Kolkman; Raj Lad; Jeffrey V. Miller; Christopher J. Murray; Scott D. Power; Brian Schmidt; Kimmenade Anita Van; Gudrun Vogtentanz


Archive | 2010

Cellulase variants with improved expression, activity and stability, and use thereof

Wolfgang Aehle; Richard R. Bott; Benjamin S. Bower; Jonathan Caspi; David A. Estell; Frits Goedegebuur; Ronaldus W. J. Hommes; Thijs Kaper; Bradley R. Kelemen; Slavko Kralj; Johannes Franciscus Thomas Van Lieshout; Igor Nikolaev; Sander Van Stigt Thans; Louise Wallace; Gudrun Vogtentanz; Mats Sandgren


Archive | 2004

Bacterial expression of bowman-birk protease inhibitors and variants thereof

Katherine D. Collier; Grant Ganshaw; Hans De Nobel; Scott D. Power; Anita Van Kimmenade; Marc Kolkman; Jeffrey V. Miller; Brian Schmidt; Gudrun Vogtentanz; David A. Estell


Archive | 2008

Modified variant Bowman Birk Protease Inhibitors

Neelam S. Amin; Katherine D. Collier; Melodie Estabrook; David A. Estell; Bryan P. Fox; Scott D. Power; Brian Schmidt; Gudrun Vogtentanz


Archive | 2008

PERSONAL CARE COMPOSITIONS COMPRISING MODIFIED VARIANT BOWMAN BIRK PROTEASE INHIBITORS

Neelam S. Amin; Katherine D. Collier; Melodie Estabrook; David A. Estell; Bryan P. Fox; Scott D. Power; Brian Schmidt; Gudrun Vogtentanz


Archive | 2010

Beta-glucosidase variants with improved properties

Richard R. Bott; Thijs Kaper; Bradley Keleman; Frits Goedegebuur; Ronaldus W. J. Hommes; Slavko Kralj; Paulien Kruithof; Igor Nikolaev; De Kley Pim Van; Lieshout Johan Van; Stigt-Thans Sander Van; Gudrun Vogtentanz; Mats Sandgren


Archive | 2008

Compositions comprising bowman-birk protease inhibitors and variants thereof

Katherine D. Collier; Grant Ganshaw; Hans De Nobel; Scott D. Power; Anita Van Kimmenade; Marc Kolkman; Jeffrey V. Miller; Brian Schmidt; Gudrun Vogtentanz; David A. Estell


Protein Journal | 2005

Monoclonal Antibodies Against Soybean Bowman-Birk Inhibitor Recognize the Protease-Reactive Loops

Yifan Mao; Cindy Lai; Gudrun Vogtentanz; Brian Schmidt; Tony Day; Jeffrey V. Miller; David L. Brandon; Dan Chen


Archive | 2010

Beta-glucosidase I variants with improved properties

Richard R. Bott; Thijs Kaper; Bradley R. Kelemen; Frits Goedegebuur; Ronaldus W. J. Hommes; Slavko Kralj; Paulien Kruithof; Igor Nikolaev; De Kley Pim Van; Lieshout Johan Van; Stigt-Thans Sander Van; Gudrun Vogtentanz; Mats Sandgren

Collaboration


Dive into the Gudrun Vogtentanz's collaboration.

Researchain Logo
Decentralizing Knowledge